Cellular Goods PLC Advertising and PR agencies appointed (0201S)

TIDMCBX

RNS Number : 0201S

Cellular Goods PLC

11 November 2021

Press release

11 November 2021

Cellular Goods PLC

("Cellular Goods" or "the Company")

Advertising and PR agencies appointed

Cellular Goods (LSE: CBX), a UK-based provider of premium consumer products formulated with lab-made cannabinoids, is pleased to announce the appointment of a consumer public relations consultant and a roster of specialist consumer advertising agencies to support the launch of its inaugural product ranges.

Good Culture has been appointed as the consumer public relations agency to drive brand and product awareness for the launch of the Company's skincare and ingestible product range. The agency has a proven track record of delivering impactful public relations and communications campaigns to a wide range of stakeholders on behalf of leading international brands, organisations, founders and celebrities.

The Company has also mandated a roster of consumer product agencies for digital advertising, content marketing and sales promotion including Cream, Rakuten, Climb Online and Numberly.

The appointments were made following a competitive pitch process, and the hired firms are well-advanced in planning their campaign strategies. The skincare and ingestible product ranges will be available to purchase from early December 2021 accompanied by a comprehensive marketing activation, building to a full omni-channel launch at the start of February 2022. The timings are in-line with industry best-practice whereby new beauty and wellness products typically go on sale early in the year to coincide with consumers' focus on self-care and forming positive habits, as well as avoiding the hyper competitive pre-Christmas rush where return on ad spend is poor for new entrants.

Alexis Abraham, chief executive of Cellular Goods, said: "Final preparations for the launch of our first range are on track. We have assembled an impressive line-up of agencies to tell our unique story and reach new customers with cost-effective and impactful strategies. It was essential to me in the selection process that they were able to grasp and communicate Cellular Goods' vision of becoming the most innovative listed wellness company, one that distances us from CBD 1.0 and captures the full promise of our development pipeline. I look forward to unveiling our products as we race towards the launch."

For further information please contact:

 
 Cellular Goods 
 Alexis Abraham                        [phone] 
  Chief Executive 
  Neil Thapar 
  Investor Relations                    [phone] 
                                      ------------------- 
 Tennyson Securities 
                                      ------------------- 
 Corporate Broker 
  Peter Krens                            [phone] 
                                      ------------------- 
 Novum Securities 
                                      ------------------- 
 Corporate Broker 
  Colin Rowbury 
  Jon Belliss                            [phone] 
                                      ------------------- 
 Tancredi Intelligent Communication 
                                      ------------------- 
 Media Relations 
  Helen Humphrey 
  Edward Daly                            [phone] 
  Salamander Davoudi                     [phone] 
  [e-mail]        [phone] 
                                      ------------------- 
 

About Cellular Goods PLC

Cellular Goods is a U.K.-based provider of premium consumer products based on lab-made cannabinoids. It was established in August 2018 to develop efficacy-led and research-backed cannabinoid products. The initial focus is on three product verticals: premium CBG skincare and CBD ingestible and topical athletic recovery products, with the first products to be launched in December 2021 initially through the Company's website.

www.cellulargoods.co

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCFBLLFFFLFFBK

(END) Dow Jones Newswires

November 11, 2021 02:00 ET (07:00 GMT)